Background
==========

Rhinitis is a common inflammatory response to allergens; it affects more than 400 million people worldwide. It is characterized by people of all ages exhibiting various symptoms, such as repetitive sneezing, nasal itching, rhinorrhea, as well as nasal obstruction \[[@b1-medscimonit-26-e924934]--[@b3-medscimonit-26-e924934]\]. While it is mostly associated with discomfort, rhinitis also increases the risk of developing bronchial hyper-responsiveness and asthma \[[@b4-medscimonit-26-e924934],[@b5-medscimonit-26-e924934]\]. Similarly, the prevalence of asthma has been growing steadily in China and globally \[[@b6-medscimonit-26-e924934]\]. These 2 common allergic diseases of the respiratory system are thought to result from complex genetic and environmental factors. Key players in the barrier system, such as airway epithelia, secret allergic mediators in response to allergen stimulation. The micro-environment, which is composed of innate immune cells, including innate lymphoid cells (ILC), and various immune effector molecules, modulates cytokines/chemokines production, which affects cells involved in adaptive immunity \[[@b7-medscimonit-26-e924934]\]. Furthermore, a mounting body of evidence implicates epigenetics and the microbiota in allergic diseases \[[@b8-medscimonit-26-e924934]\].

Asthma and rhinitis are common allergic conditions of the respiratory system. Epidemiological reports show that the incidence of asthma and rhinitis is rising, negatively affecting patients' health and quality of life \[[@b9-medscimonit-26-e924934]\]. Rhinitis has been shown to be closely correlated with the physiology, pathology, and pathogenesis of asthma \[[@b10-medscimonit-26-e924934]--[@b12-medscimonit-26-e924934]\]. It is estimated that 40--50% of people with rhinitis will develop asthma and 74--90% of people with allergic asthma also have rhinitis \[[@b7-medscimonit-26-e924934],[@b9-medscimonit-26-e924934],[@b13-medscimonit-26-e924934]\]. These observations gave rise to the theory of "one airway, one disease" that posits a close relationship between asthma and rhinitis \[[@b14-medscimonit-26-e924934]\].

Rhinitis is a complex disorder thought to result from the interaction between over 100 genetic *loci* and complex environmental factors \[[@b15-medscimonit-26-e924934]\]. However, there is no satisfactory treatment for allergic diseases, and a strategy combining the treatment of both compartments appears to be optimal. Therefore, there is an urgent need to better understand the pathogenesis and genetic modulators of allergic diseases to develop effective therapies. In this study, we identified genes that are co-differentially-expressed (co-DEGs) between persistent rhinitis and asthma. We then investigated the molecular mechanisms through which the rhinitis-related DEGs and asthma-related DEGs drive pathogenesis. Finally, using bioinformatic analysis of the DEGs, we predicted microRNAs that may be involved in the process of rhinitis patients' developing asthma.

Material and Methods
====================

GSE104468 and GSE46171 datasets were downloaded from the GEO database (*<http://www.ncbi.nlm.nih.gov/geo/>*) \[[@b16-medscimonit-26-e924934]\] and expression profiling arrays were generated using GPL21185 Agilent-072363 SurePrint G3 Human GE v3 8×60K Microarray (Agilent, Santa Clara, CA) and GPL6480 Agilent-014850 Whole Human Genome Microarray 4×44K G4112F (Agilent, Santa Clara, CA), respectively. Additionally, the GSE104468 dataset, including collected nasal epithelia and bronchial epithelia sample from 12 subjects with allergic asthma and 12 control subjects, was used to identify differentially-expressed genes and molecular mechanisms of asthma \[[@b17-medscimonit-26-e924934]\]. In this study, the nasal epithelia and bronchial epithelia expression profiles were used to explore the comorbidity rate of rhinitis and asthma. Nasal epithelia samples of GSE46171 were collected from adults with asthma, allergic rhinitis, or no underlying respiratory disease. Nasal mucosa sampling was taken on day 2 and day 6 of symptomatic illness, and an asymptomatic BL sample was taken at least 29 days later \[[@b18-medscimonit-26-e924934]\]. Traditionally, general research about asthma has always focused on bronchial epithelia. In order to conduct joint research with rhinitis, we found target genes on the nasal epithelia of asthma patients at the same time, allowing us to analyze common target genes of rhinitis and asthma. Common target genes were found in 2 different tissues of asthma patients, then the correlation between asthma and rhinitis was analyzed, and underlying biomarkers and therapeutic targets of comorbid rhinitis and asthma were revealed.

Data processing
---------------

The Bioconductor R packages "limma" \[[@b19-medscimonit-26-e924934]\], was applied to analyze GSE104468 and GSE46171 RAW datasets. Original p-values were corrected using the Benjamini-Hochberg method. The following gene expression thresholds were applied to identify DEGs: fold-change \>1.5 or \<0.6667. Co-DEGs were visualized by plotting the respective co-DEGs for rhinitis and asthma on Venn diagrams.

Finally, an online prediction tool utilizing microRNA data integration portal (mirDIP) was used \[[@b20-medscimonit-26-e924934]\] to predict potential microRNA targeting. mirDIP was then used to predict which of the identified miRNAs target co-DEGs and to select the top 5 candidate miRNAs.

Identification of protein--protein interaction (PPI) networks of DEGs
---------------------------------------------------------------------

The Search Tool for the Retrieval of Interacting Genes (STRING database, V11; *<http://string-db.org/>*) was used to create a PPI network of rhinitis and asthma DEGs to predict protein--protein interactions and the functions of the DEGs \[[@b21-medscimonit-26-e924934]\]. Subsequently, Cytoscape software (V3.5.2; *<http://cytoscape.org/>*) was used to visualize and analyze biological networks and node degrees based on a confidence score \>0.4 \[[@b22-medscimonit-26-e924934]\].

GO and KEGG functional enrichment analysis
------------------------------------------

Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of rhinitis and asthma DEGs were performed using Bioconductor's "clusterProfiler" package in R \[[@b23-medscimonit-26-e924934]\]. GO terms of biological processes, cellular components, and molecular functions associated with a p-value \<0.05 were considered to be significantly enriched.

Identification of co-DEGs associated with respiratory diseases
--------------------------------------------------------------

To generate expanded networks and predict novel associations, the comparative toxicogenomics database (*<http://ctdbase.org/>*) was used to identify integrated chemical-gene, chemical-disease, and gene-disease interactions \[[@b24-medscimonit-26-e924934],[@b25-medscimonit-26-e924934]\]. These data were analyzed for relationships between genes and respiratory disease like rhinitis and asthma, and we identified relationships between co-DEGs and diseases and association or an implied association.

Results
=======

Identification of DEGs
----------------------

We identified 58 201 probes in GSE104468 dataset and confirmed 687 genes as DEGs in bronchial epithelia specimens, and 1353 probes corresponding to 1001 DEGs were identified in nasal epithelia samples ([Figure 1](#f1-medscimonit-26-e924934){ref-type="fig"}). In the GSE58294 dataset, we defined 245 rhinitis DEGs ([Figure 2](#f2-medscimonit-26-e924934){ref-type="fig"}). Except for the inconsistent upregulation and downregulation of the ADTRP gene in the bronchial epithelia and nasal epithelia dataset, 6 co-DEGs emerged: BPIFA1, CCL26, CPA3, CST1, CST2, and FETUB.

Functional enrichment in co-DEGs
--------------------------------

Intriguingly, 6 co-expressed DEGs -- BPI fold containing family A member 1 (BPIFA1), C-C motif chemokine ligand 26 (CCL26), carboxypeptidase A3 (CPA3), cystatin SN (CST1), cystatin SA (CST2), and fetuin B (FETUB) -- were observed.

Next, we used the AmiGO database to confirm GO term enrichment related to the biological processes, cellular components, and molecular functions, and found that the co-DEGs were associated with miscellaneous processes ([Table 1](#t1-medscimonit-26-e924934){ref-type="table"}).

Functional GO terms and pathway enrichment analyses and PPI network analysis
----------------------------------------------------------------------------

Analysis of PPI networks of rhinitis DEGs and asthma DEGs revealed 263 and 42 nodes, respectively ([Figure 3](#f3-medscimonit-26-e924934){ref-type="fig"}). Paired box 6 (PAX6; degree=13), neuromedin U (NMU; degree=12), neurotensin (NTS; degree=12), neuromedin U receptor 1 (NMUR1; degree=11), pro-melanin concentrating hormone (PMCH; degree=11), and keratin 6A (KRT6A; degree=10) are considered hub-genes related to rhinitis. However, the hub-genes involved in carboxypeptidase A3 (CPA3; degree=8), cathepsin G (CTSG; degree=5), periostin (POSTN; degree=5), chloride channel accessory 1 (CLCA1; degree=4), and histidine decarboxylase (HDC; degree=4) are demonstrated in asthma DEGs at relatively higher degree.

GO term analysis for biological processes indicated that these genes are significantly associated with epidermis development (p-value: 1.91E-07), keratinocyte differentiation (p-value: 8.57E-07), epidermal cell differentiation (p-value: 1.53E-06), skin development (p-value: 3.09E-06), and cornification (p-value: 7.97E-06). In the cellular components, DEGs were significantly correlated with haptoglobin-hemoglobin complex (p-value: 5.58E-06), hemoglobin complex (p-value: 8.3E-06), and intermediate filament cytoskeleton (p-value: 1.85E-04). In the molecular function component, DEGs were mainly involved in haptoglobin binding (p-value: 4.94E-06), oxygen carrier activity (p-value: 2.26E-05), and oxygen binding (p-value: 8.51E-05). Analysis of the relationship between asthma DEGs and biological processes indicated they are significantly associated with regulation of extracellular matrix organization (p-value: 1.36E-06), extracellular structure organization (p-value: 4.18E-06), regulation of systemic arterial blood pressure by renin-angiotensin (p-value: 6.33E-05), and extracellular matrix disassembly (p-value: 9.69E-05). There are significant correlations in collagen-containing extracellular matrix (p-value: 1.62E-04), catenin complex (p-value: 0.0032), and vacuolar lumen (p-value: 0.014) in relation to cellular components. Similarly, the terms of endopeptidase inhibitor activity (p-value: 1.5E-05), peptidase inhibitor activity (p-value: 1.87E-05), and endopeptidase regulator activity (p-value: p-value: 1.87E-05) related to molecular functions were primarily enriched ([Figure 4](#f4-medscimonit-26-e924934){ref-type="fig"}).

KEGG pathway analysis data are shown in [Figure 5](#f5-medscimonit-26-e924934){ref-type="fig"}. KEGG pathway analysis indicated that rhinitis DEGs are mainly enriched for pathways of renin-angiotensin system (p-value: 0.0035), malaria (p-value: 0.0046), salivary secretion (p-value: 0.0075), and lysosome (p-value: 0.0078). However, these KEGG terms, including salivary secretion (p-value: 3.96E-05), renin-angiotensin system (p-value: 0.0044), and lysosome (p-value: 0.018) are also enriched in asthma DEGs.

Identification of functional and pathway enrichment among predicted miRNAs and co-DEGs
--------------------------------------------------------------------------------------

The CTD database revealed that co-DEGs targeted various nasal sinus and respiratory system diseases ([Figure 6](#f6-medscimonit-26-e924934){ref-type="fig"}, [Supplementary Table 1](#s1-medscimonit-26-e924934){ref-type="supplementary-material"}). By setting an inference score filter at \>5, we found that BPIFA1, CCL26, CPA3, and CST1 are associated with asthma and rhinitis. Next, we mirDIP analysis was done to predict microRNAs that may regulate the 4 genes and the top 5 predicted microRNAs for each gene, along with related pathway enrichment selected ([Table 2](#t2-medscimonit-26-e924934){ref-type="table"}). These analyses provided insight into the mechanisms by which the predicted miRNAs influence rhinitis-asthma comorbidity.

Discussion
==========

Rhinitis, a chronic inflammatory cascade in nasal mucosa mediated by allergen-specific IgE, is clinically characterized by pruritus, sneezing, and rhinorrhea \[[@b26-medscimonit-26-e924934]\]. Studies of the nose-bronchi functional links have indicated that allergy is not a disease localized to a specific organ, but is rather a disorder of the entire respiratory tract, exhibiting a wide range of symptoms \[[@b27-medscimonit-26-e924934]\]. Rhinitis has been identified as an independent risk factor for asthma development. Therefore, development of effective treatments for rhinitis effectively prevent or delay asthma onset \[[@b28-medscimonit-26-e924934]\]. Endotype-driven treatments of upper-airway disease are effective against asthma. Four categories of asthma are recognized based and can be managed by specific treatments \[[@b29-medscimonit-26-e924934]\]. Knowledge about type 2 inflammation much more advanced relative to other endotypes. Type 2 targeted treatments with monoclonal antibodies against IgE, IL5, and IL4Rα have been proven to be effective in the management of chronic upper-airway diseases. Neurogenic inflammation has been shown to cause nasal hyperreactivity and it can be effectively managed with capsaicin \[[@b30-medscimonit-26-e924934]\]. Endotype-driven treatment can be used as a reference for rhinitis management since treatment options for rhinitis are still in their infancy due to the lack of suitable classification indexes. Accumulating evidence has demonstrated the roles of microRNAs and long non-coding RNAs in the modulation of disease pathology \[[@b31-medscimonit-26-e924934],[@b32-medscimonit-26-e924934]\]. However, factors that negatively impact nasal conditioning during rhinitis have not been systematically evaluated. Therefore, the identification of biomarkers for the association between rhinitis and asthma are of great interest and could facilitate therapeutic strategies. Here, we identified several rhinitis-asthma co-DEGs that directly or indirectly regulate the respiratory system.

Bacterial permeability family member A1 (BPIFA1), also known as the short palate, lung, and nasal epithelium clone 1 (SPLUNC1), is an epithelium-secreted protein involved in innate immunity and anti-inflammatory responses. It is one of the most abundant proteins in respiratory secretions and has been implicated with increasing frequency in pulmonary disease. Reduced BPIFA1 expression may contribute to the persistent nature of bacterial infections in airways, suggesting that BPIFA1 may serve as a host defense protein against bacterial infection \[[@b33-medscimonit-26-e924934],[@b34-medscimonit-26-e924934]\]. Better understanding of the role of BPIFA1 in disease pathogenesis will elucidate its potential as a biomarker and potential drug target against pulmonary disease. Nasal SPLUNC1 expression is inhibited by Th2 cytokines (IL-4 and IL-13) \[[@b35-medscimonit-26-e924934],[@b36-medscimonit-26-e924934]\] but stimulated by Toll-like receptor (TLR) agonists and glucocorticoids \[[@b37-medscimonit-26-e924934]\].

Recent studies have shown that the chemokine CCL26 mediates eosinophilic inflammation diseases by promoting eosinophils infiltration from peripheral blood into affected organs. CCL26 is the important acidophilic granulocyte chemokine for IL-13-induced epithelial cell generation \[[@b38-medscimonit-26-e924934]--[@b40-medscimonit-26-e924934]\]. Additionally, eosinophilic and neutrophilic asthma endotypes are defined by epithelium-derived CCL26 and osteopontin, respectively \[[@b41-medscimonit-26-e924934]\].

As a member of the type 2 cystatin (CST) superfamily, CST1 is known to inhibit proteolytic activities of cysteine proteases and is involved in the progression of several human cancers \[[@b42-medscimonit-26-e924934]\]. CST1 expression is elevated in the nasal epithelia of patients with allergic rhinitis \[[@b43-medscimonit-26-e924934]\]. A previous study that constructed an allergic rhinitis-specific transcriptional regulatory network ranked CST1 as the most differentially-expressed gene in AR \[[@b44-medscimonit-26-e924934]\].

We identified miR-195-5p, miR-16-5p, and miR-125a-3p as co-DEGs that may serve as potential biomarkers for rhinitis and asthma. Interestingly, previous studies have reported that miR-195-5p inhibits cell migration and invasion in cervical carcinoma by suppressing ARL2 \[[@b45-medscimonit-26-e924934]\]. Similarly, circulating miR-16-5p and miR-19b-3p have been proposed as novel biomarkers for gastric cancer progression due to their ability to inhibit cell proliferation, invasion, and metastasis \[[@b46-medscimonit-26-e924934]\]. Aberrant expression of miR-125a-3p is associated with fibroblast activation. Regulation of miR-125a-3p levels may be a novel treatment option against proliferative vascular diseases \[[@b47-medscimonit-26-e924934]\].

Conclusions
===========

CPA3, CTSG, POSTN, CLCA1, HDC, and MUC5B may be involved in asthma, and the hub-genes of PAX6, NMU, NTS, NMUR1, PMCH, and KRT6A may be associated with rhinitis. Besides, co-expressed DEGs of BPIFA1, CCL26, CPA3, and CST1 connect rhinitis and asthma. Lastly, the top 5 corresponding predicted miRNAs of each co-DEGs could be underlying biomarkers or therapeutic targets for rhinitis-related asthma, especially miR-195-5p, miR-16-5p, and miR-125a-3p. Therefore, rhinitis and asthma are related, and the co-expression of BPIFA1, CCL26, CPA3, and CST1 genes revealed the comorbidity of rhinitis and asthma.

Supplementary Data
==================

###### 

The relationship between co-expressed genes and respiratory system diseases based on the CTD database.

  Gene symbol   Gene ID   Disease name                    Disease ID      Direct evidence    Inference network                                                                                                                          Inference score   Reference count
  ------------- --------- ------------------------------- --------------- ------------------ ------------------------------------------------------------------------------------------------------------------------------------------ ----------------- -----------------
  BPIFA1        51297     Rhinitis                        MESH: D012220                      Particulate Matter \| Tobacco Smoke Pollution \| Vehicle Emissions                                                                         12.67             3
  BPIFA1        51297     Rhinitis, allergic              MESH: D065631                      Particulate Matter \| Soot                                                                                                                 8.45              2
  BPIFA1        51297     Rhinitis, allergic, seasonal    MESH: D006255                      Particulate Matter                                                                                                                         3.57              1
  BPIFA1        51297     Asthma                          MESH: D001249                      Acetaminophen \| Arsenic \| Particulate Matter \| Soot \| Tobacco Smoke Pollution \| Vehicle Emissions                                     21.02             29
  BPIFA1        51297     Asthma, occupational            MESH: D059366                      Silicon Dioxide                                                                                                                            3.35              1
  BPIFA1        51297     Nose diseases                   MESH: D009668                      Propylthiouracil \| Tobacco Smoke Pollution                                                                                                9.59              4
  CCL26         10344     Asthma                          MESH: D001249                      Aerosols \| Antigens, Dermatophagoides \| Arsenic \| Cadmium \| Dexamethasone \| Ozone \| Resveratrol \| Tobacco Smoke Pollution \| Zinc   27.99             28
  CCL26         10344     Rhinitis, allergic, perennial   MESH: D012221                      Ozone                                                                                                                                      3.73              1
  CCL26         10344     Rhinitis, allergic              MESH: D065631                      Atrazine                                                                                                                                   2.83              1
  CCL26         10344     Rhinitis                        MESH: D012220                      Tobacco Smoke Pollution                                                                                                                    2.6               1
  CCL26         10344     Nose diseases                   MESH: D009668                      Lipopolysaccharides \| Propylthiouracil \| Tobacco Smoke Pollution                                                                         14.31             5
  CCL26         10344     Sinusitis                       MESH: D012852                      Tobacco Smoke Pollution                                                                                                                    2.9               1
  CPA3          1359      Rhinitis                        MESH: D012220                      Tobacco Smoke Pollution \| Vehicle Emissions                                                                                               6.86              2
  CPA3          1359      Asthma                          MESH: D001249                      Acetaminophen \| Decitabine \| epigallocatechin gallate \| Tobacco Smoke Pollution \| trimellitic anhydride \| Vehicle Emissions           18.84             19
  CPA3          1359      Nose diseases                   MESH: D009668                      Tobacco Smoke Pollution                                                                                                                    3.4               2
  CPA3          1359      Sinusitis                       MESH: D012852                      Acetaminophen \| Tobacco Smoke Pollution                                                                                                   7.83              2
  CST1          1469      Rhinitis, allergic, seasonal    MESH: D006255   Marker/mechanism                                                                                                                                              1                 
  CST1          1469      Rhinitis, allergic              MESH: D065631                      Air Pollutants                                                                                                                             3.83              1
  CST1          1469      Rhinitis                        MESH: D012220                      Air Pollutants                                                                                                                             3.6               1
  CST1          1469      Asthma                          MESH: D001249                      Air Pollutants \| Methotrexate \| Tretinoin                                                                                                9.41              14
  CST1          1469      Asthma, occupational            MESH: D059366                      Silicon Dioxide                                                                                                                            3.45              1
  CST2          1470      Asthma, occupational            MESH: D059366                      Silicon Dioxide                                                                                                                            3.85              1
  FETUB         26998     Rhinitis                        MESH: D012220                      Tobacco Smoke Pollution \| Vehicle Emissions                                                                                               5.71              2
  FETUB         26998     Rhinitis, allergic              MESH: D065631                      Atrazine                                                                                                                                   2.66              1
  FETUB         26998     Nose diseases                   MESH: D009668                      cobaltous chloride \| Tobacco Smoke Pollution                                                                                              7.86              3
  FETUB         26998     Sinusitis                       MESH: D012852                      Acetaminophen \| Tobacco Smoke Pollution                                                                                                   6.66              2
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![Heatmap of clustering analysis for asthma-related differentially-expressed genes. **Left panel** shows the heatmap of differentially-expressed genes in bronchial epithelia sample, while **right panel** shows the heatmap of differentially-expressed genes in nasal epithelia sample.](medscimonit-26-e924934-g001){#f1-medscimonit-26-e924934}

![Hierarchical clustering analysis and the heatmap of rhinitis-related differentially-expressed genes. Red -- greater expression. Green -- less expression.](medscimonit-26-e924934-g002){#f2-medscimonit-26-e924934}

![PPI network of asthma- and rhinitis-related DEGs. PPI networks from asthma and rhinitis constructed using STRING database for DEGs (threshold \>0.4). Red, greater degree. Yellow, lesser degree.](medscimonit-26-e924934-g003){#f3-medscimonit-26-e924934}

![Gene Ontology categories of asthma- and rhinitis-related DEGs.](medscimonit-26-e924934-g004){#f4-medscimonit-26-e924934}

![KEGG pathway enrichment of asthma- and rhinitis-related DEGs.](medscimonit-26-e924934-g005){#f5-medscimonit-26-e924934}

![(**A--D**) Relationship to respiratory system diseases related to co-expressed genes based on the CTD database.](medscimonit-26-e924934-g006){#f6-medscimonit-26-e924934}

###### 

The Gene Ontology (GO) terms enrichment for the co-expressed genes of rhinitis and asthma.

  Gene/product                                                                     GO class (direct)                                                               Evidence                  Reference
  -------------------------------------------------------------------------------- ------------------------------------------------------------------------------- ------------------------- -------------------------
  BPIFA1                                                                           Protein binding                                                                 IPI                       PMID: 25416956
  Extracellular region                                                             IDA                                                                             PMID: 11425234            
  Extracellular space                                                              IDA                                                                             PMID: 21805676            
  Lipid binding                                                                    IEA                                                                             GO_REF: 0000037           
  Antimicrobial humoral response                                                   TAS                                                                             Reactome: R-HSA-6803157   
  Antibacterial humoral response                                                   IDA                                                                             PMID: 23499554            
  Innate immune response                                                           IDA                                                                             PMID: 23499554            
  Regulation of liquid surface tension                                             IDA                                                                             PMID: 23499554            
  Multicellular organismal water homeostasis                                       IDA                                                                             PMID: 24124190            
  Defense response to virus                                                        IEP                                                                             PMID: 21805676            
  Antimicrobial humoral immune response mediated by antimicrobial peptide          IEP                                                                             PMID: 21805676            
  Negative regulation of single-species biofilm formation in or on host organism   IMP                                                                             PMID: 23499554            
  Regulation of sodium ion transmembrane transport                                 IDA                                                                             PMID: 24124190            
  *CCL26*                                                                          Positive regulation of endothelial cell proliferation                           IDA                       PMID: 19525930
  Monocyte chemotaxis                                                              IDA                                                                             PMID: 10373330            
  Protein binding                                                                  IPI                                                                             PMID: 28381538            
  Extracellular space                                                              IDA                                                                             PMID: 10373330            
  Chemotaxis                                                                       TAS                                                                             PMID: 10373330            
  Signal transduction                                                              NAS                                                                             PMID: 10373330            
  Cell--cell signaling                                                             TAS                                                                             PMID: 10373330            
  Chemokine activity                                                               IDA                                                                             PMID: 10373330            
  T cell chemotaxis                                                                IDA                                                                             PMID: 10373330            
  Positive regulation of cell migration                                            IDA                                                                             PMID: 19525930            
  Positive regulation of actin filament polymerization                             IDA                                                                             PMID: 19525930            
  CCR3 chemokine receptor binding                                                  IDA                                                                             PMID: 11425309            
  Positive regulation of GTPase activity                                           IDA                                                                             PMID: 19525930            
  Receptor ligand activity                                                         IDA                                                                             PMID: 11425309            
  Positive regulation of chemotaxis                                                IDA                                                                             PMID: 10373330            
  Chemokine-mediated signaling pathway                                             IDA                                                                             PMID: 10373330            
  CCR chemokine receptor binding                                                   IBA                                                                             PMID: 21873635            
  Positive regulation of GTPase activity                                           IBA                                                                             PMID: 21873635            
  Lymphocyte chemotaxis                                                            IBA                                                                             PMID: 21873635            
  Chemokine activity                                                               IBA                                                                             PMID: 21873635            
  Monocyte chemotaxis                                                              IBA                                                                             PMID: 21873635            
  Cellular response to tumor necrosis factor                                       IBA                                                                             PMID: 21873635            
  Extracellular space                                                              IBA                                                                             PMID: 21873635            
  Inflammatory response                                                            IBA                                                                             PMID: 21873635            
  Chemokine-mediated signaling pathway                                             IBA                                                                             PMID: 21873635            
  G protein-coupled receptor signaling pathway                                     IBA                                                                             PMID: 21873635            
  Cellular response to interleukin-1                                               IBA                                                                             PMID: 21873635            
  Neutrophil chemotaxis                                                            IBA                                                                             PMID: 21873635            
  Positive regulation of ERK1 and ERK2 cascade                                     IBA                                                                             PMID: 21873635            
  Cellular response to interferon-gamma                                            IBA                                                                             PMID: 21873635            
  *CPA3*                                                                           Angiotensin maturation                                                          TAS                       Reactome: R-HSA-2028294
  Metallocarboxypeptidase activity                                                 TAS                                                                             PMID: 1629626             
  Extracellular region                                                             TAS                                                                             Reactome: R-HSA-2028294   
  Proteolysis                                                                      TAS                                                                             PMID: 2708524             
  Zinc ion binding                                                                 IEA                                                                             GO_REF: 0000002           
  Transport vesicle                                                                IEA                                                                             GO_REF: 0000039           
  Secretory granule                                                                NAS                                                                             PMID: 2594780             
  Collagen-containing extracellular matrix                                         HDA                                                                             PMID: 27559042            
  Metallocarboxypeptidase activity                                                 IBA                                                                             PMID: 21873635            
  Proteolysis                                                                      IBA                                                                             PMID: 21873635            
  Extracellular space                                                              IBA                                                                             PMID: 21873635            
  *CST1*                                                                           Detection of chemical stimulus involved in sensory perception of bitter taste   IDA                       PMID: 24248522
  Cysteine-type endopeptidase inhibitor activity                                   IEA                                                                             GO_REF: 0000037           
  Protein binding                                                                  IPI                                                                             PMID: 25416956            
  Extracellular space                                                              HDA                                                                             PMID: 22664934            
  Negative regulation of endopeptidase activity                                    IEA                                                                             GO_REF: 0000108           
  Extracellular space                                                              IBA                                                                             PMID: 21873635            
  *CST2*                                                                           Detection of chemical stimulus involved in sensory perception of bitter taste   IDA                       PMID: 24248522
  Cysteine-type endopeptidase inhibitor activity                                   IEA                                                                             GO_REF: 0000037           
  Protein binding                                                                  IPI                                                                             PMID: 25416956            
  Extracellular space                                                              HDA                                                                             PMID: 22664934            
  Negative regulation of endopeptidase activity                                    IEA                                                                             GO_REF: 0000108           
  Extracellular space                                                              IBA                                                                             PMID: 21873635            
  *FETUB*                                                                          Cysteine-type endopeptidase inhibitor activity                                  IEA                       GO_REF: 0000002
  Single fertilization                                                             ISS                                                                             GO_REF: 0000024           
  Binding of sperm to zona pellucida                                               ISS                                                                             GO_REF: 0000024           
  Metalloendopeptidase inhibitor activity                                          ISS                                                                             GO_REF: 0000024           
  Negative regulation of endopeptidase activity                                    ISS                                                                             GO_REF: 0000024           
  Extracellular exosome                                                            HDA                                                                             PMID: 23533145            
  Binding of sperm to zona pellucida                                               IBA                                                                             PMID: 21873635            
  Negative regulation of endopeptidase activity                                    IBA                                                                             PMID: 21873635            
  Metalloendopeptidase inhibitor activity                                          IBA                                                                             PMID: 21873635            
  Extracellular region                                                             IBA                                                                             PMID: 21873635            
  Endopeptidase inhibitor activity                                                 IBA                                                                             PMID: 21873635            

###### 

The Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enrichment among predicted miRNAs and co-DEGs.

  Genes                                                                            Predicted miRNAs                               Category                                                                 P value
  -------------------------------------------------------------------------------- ---------------------------------------------- --------------------------------------------- -------------------------- ----------
  *BPIFA1*                                                                         hsa-miR-195-5p                                 KEGG pathway                                  Fatty acid biosynthesis    1.04E-07
  hsa-miR-16-5p                                                                    Adherens junction                              1.70E-07                                                                 
  hsa-miR-424-5p                                                                   TGF-beta signaling pathway                     3.28E-05                                                                 
  hsa-miR-497-5p                                                                   GO terms                                       Neurotrophin TRK receptor signaling pathway   1.79E-31                   
  hsa-miR-15b-5p                                                                   cell death                                     1.41E-28                                                                 
  Response to stress                                                               1.41E-28                                                                                                                
  Blood coagulation                                                                1.84E-25                                                                                                                
  Fc-epsilon receptor signaling pathway                                            5.45E-19                                                                                                                
  Immune system process                                                            3.87E-15                                                                                                                
  Activation of signaling protein activity involved in unfolded protein response   3.77E-14                                                                                                                
  Toll-like receptor 10 signaling pathway                                          1.22E-13                                                                                                                
  Epidermal growth factor receptor signaling pathway                               1.82E-13                                                                                                                
  Toll-like receptor TLR1: TLR2 signaling pathway                                  1.06E-12                                                                                                                
  Toll-like receptor TLR6: TLR2 signaling pathway                                  1.06E-12                                                                                                                
  *CCL26*                                                                          hsa-miR-326                                    KEGG pathway                                  Steroid biosynthesis       8.04E-10
  hsa-miR-615-5p                                                                   ECM-receptor interaction                       3.39E-08                                                                 
  hsa-miR-559                                                                      GO terms                                       Neurotrophin TRK receptor signaling pathway   5.30E-26                   
  hsa-miR-335-5p                                                                   Small molecule metabolic process               5.89E-21                                                                 
  hsa-miR-548d-5p                                                                  Blood coagulation                              8.06E-18                                                                 
  Cellular protein modification process                                            4.43E-15                                                                                                                
  Fc-epsilon receptor signaling pathway                                            3.94E-13                                                                                                                
  Cellular nitrogen compound metabolic process                                     3.94E-13                                                                                                                
  Immune system process                                                            7.59E-11                                                                                                                
  *CPA3*                                                                           hsa-miR-125a-3p                                KEGG pathway                                  Adherens junction          2.60E-07
  hsa-miR-155-5p                                                                   Hippo signaling pathway                        1.21E-05                                                                 
  hsa-miR-196a-5p                                                                  TGF-beta signaling pathway                     1.96E-05                                                                 
  hsa-miR-196b-5p                                                                  Lysine degradation                             4.43E-05                                                                 
  GO terms                                                                         cellular nitrogen compound metabolic process   6.05E-108                                                                
  gene expression                                                                  7.55E-68                                                                                                                
  biosynthetic process                                                             8.95E-64                                                                                                                
  cellular protein modification process                                            8.70E-52                                                                                                                
  *CST1*                                                                           hsa-miR-452-5p                                 KEGG pathway                                  ECM-receptor interaction   0.000132
  hsa-miR-608                                                                      Hippo signaling pathway                        0.00019                                                                  
  hsa-miR-138-5p                                                                   Adherens junction                              0.00019                                                                  
  hsa-miR-4685-5p                                                                  Apoptosis                                      0.005037                                                                 
  hsa-miR-1321                                                                     Focal adhesion                                 0.005037                                                                 
  GO terms                                                                         Cellular nitrogen compound metabolic process   2.81E-42                                                                 
  Gene expression                                                                  2.91E-40                                                                                                                
  Biosynthetic process                                                             7.87E-34                                                                                                                
  mRNA metabolic process                                                           8.00E-21                                                                                                                
  Response to stress                                                               8.00E-21                                                                                                                
  RNA metabolic process                                                            1.38E-17                                                                                                                
  Symbiosis, encompassing mutualism through parasitism                             1.97E-17                                                                                                                
  Cellular component assembly                                                      2.11E-17                                                                                                                
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